Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Evidence on risk of breast cancer associated with hormone replacement therapy is still inconclusive

  1. Karen Mckinney, Senior registrar
  1. Department of Obstetrics and Gynaecology, Queen's University of Belfast, Institute of Clinical Science, Belfast, BT7 1NN

    EDITOR,—As a female doctor who has a specialist interest in the menopause and hormone replacement therapy, I was interested to read Elizabeth H Price and Helen Kaye Little's letter about hormone replacement therapy.1 I agree that women need to be informed about the risks associated with such treatment. I disagree, however, with the authors' statements about the increased risk of breast cancer.

    The epidemiological evidence on the effect of combined treatment with …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular